Yaron Samid
Founder & Managing Partner, TechAviv. 3X founder & CEO, investor, and community builder.
Tel Aviv District
Invests in
Sectors:
Min Investment:
$500,000.00Max Investment:
$3,000,000.00Target Investment:
$1,000,000.00
Skills
Education
- T-
- Uo
Lists including Yaron
Investments
Somite
Total Funding: $5M
retrain.ai
Total Funding: $34M
Leo AI
Total Funding:
Jit
Total Funding: $47M
One AI
Total Funding: $8M
Oshi
Total Funding: $14M
Aktivate
Total Funding: $9M
Nas Academy
Total Funding: $11M
Plantish
Total Funding: $2M
Flytrex
Total Funding: $51M
Work Experience
2007
Managing Partner
2020
TechAviv Founder Partners is a pre-seed venture fund backed and powered by 150 of the world’s most successful company builders, including 37 unicorn founders, public company CEOs, tech-giant execs, and top-tier VCs. We’ve joined forces across 6 continents and 28 sectors of expertise to actively scout and support elite Israeli founders building transformative tech companies globally.
Founder
2007
The TechAviv Founders Club is a private global network of Israeli startup founders that connect on and offline, harnessing our collective energy, knowledge, and networks to help each other build better companies. Since 2007 our members have built over 130 billion-dollar companies.
2023
Seed Investor
2023
The future of AI is open-source. Together AI's decentralized cloud services empower developers and researchers at organizations of all sizes to train, fine-tune, and deploy open-source generative AI models.
2020
Seed Investor
2020
Torq is a no-code automation platform for security and ops teams.
2024
Seed Investor
2024
Somite.ai is building the OpenAI of stem cell biology. The company develops AI foundation models to produce human tissue for cell therapies at scale for diseases such as diabetes, obesity, and muscular dystrophies.
2022
Seed Investor
2022
Descope is a frictionless, secure, and developer-friendly authentication and user management platform.
2023
Pre-Seed Investor & Board Member
2023
The world’s first engineering design copilot.
2024
Pre-Seed Investor & Board Member
2024
Fixing the multi-billion dollar transitional care gap.
2022
Pre-Seed Investor
2022
The Hybrid Drug Company
2025
Seed Investor
2025
Numenos is saving lives through AI-driven Foundation Models, custom-built to reshape drug discovery and development.
2021
Seed Investor & Board Observer
2021
The Agentic AppSec Platform That Gets Work Done